NCT02241434撤回1 期
The Role of Autologous Bone Marrow Mononuclear Cell Therapy in Duchenne Muscular Dystrophy
适应症
干预措施
试验速览
- 阶段
- 1 期
- 状态
- 撤回
- 试验地点
- 2
- 主要终点
- Manual Muscle Testing
研究概览
简要总结
The purpose of this study was to study the effect of stem cell therapy in patients with Duchenne Muscular Dystrophy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 3 Years 至 25 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •age group of 3-25 years
- •Duchenne muscular dystrophy diagnosed on the basis of clinical presentation
排除标准
- •presence of respiratory distress
- •presence of acute infections such as Human Immunodeficient Virus/Hepatitis B Virus/Hepatitis C Virus
- •malignancies
- •acute medical conditions such as respiratory infection, fever, hemoglobin less than 8, bleeding tendency, bone marrow disorder, left ventricular ejection fraction < 30%
- •pregnancy or breastfeeding
研究组 & 干预措施
Stem Cell
Experimental
bone marrow mononuclear cell transplantation
干预措施: Stem Cell (Biological)
结局指标
主要结局
Manual Muscle Testing
时间窗: 1 year
次要结局
- Brooke and Vignos Scale(1 year)
研究者
研究点 (2)
Loading locations...
相似试验
撤回
1 期
Stem Cell Therapy in Muscular DystrophyMuscular DystrophyNCT02241928Neurogen Brain and Spine Institute
撤回
1 期
Autologous Stem Cell Therapy in StrokeStrokeNCT02245698Neurogen Brain and Spine Institute
撤回
1 期
Cell Therapy as Treatment for Cerebral PalsyCerebral PalsyNCT02241395Neurogen Brain and Spine Institute
撤回
1 期
Stem Cell Therapy in Incurable Neurological DisordersDisorder, Nervous System NeurologicalNCT02245776Neurogen Brain and Spine Institute
撤回
1 期
Safety and Efficacy of Autologous Stem Cell Therapy in Chronic StrokeCerebrovascular AccidentNCT02065778Neurogen Brain and Spine Institute